{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:33:33Z","timestamp":1782830013015,"version":"3.54.5"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00108-015-3806-9","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T16:42:09Z","timestamp":1453135329000},"page":"25-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chronische Absto\u00dfung","Chronic rejection"],"prefix":"10.1007","volume":"57","author":[{"given":"H.","family":"Suhling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Taubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"J\u00e4ckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Br\u00e4sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"key":"3806_CR1","doi-asserted-by":"crossref","unstructured":"Yusen RD, Edwards LB, Kucheryavaya AY et\u00a0al (2014) The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report \u2013 2014; focus theme: retransplantation. J\u00a0Heart Lung Transplant 33(10):1009\u20131024","DOI":"10.1016\/j.healun.2014.08.004"},{"key":"3806_CR2","doi-asserted-by":"crossref","unstructured":"Christie JD, Edwards LB, Aurora P et\u00a0al (2009) The Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult lung and heart-lung transplantation report-2009. J\u00a0Heart Lung Transplant 28(10):1031\u20131049","DOI":"10.1016\/j.healun.2009.08.004"},{"key":"3806_CR3","doi-asserted-by":"crossref","unstructured":"Bando K, Paradis IL, Similo S et\u00a0al (1995) Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J\u00a0Thorac Cardiovasc Surg 110(1):4\u201313","DOI":"10.1016\/S0022-5223(05)80003-0"},{"key":"3806_CR4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-2006-954609","volume":"27","author":"Knoop","year":"2006","unstructured":"Knoop C, Estenne M (2006) Acute and chronic rejection after lung transplantation. Semin Respir Crit Care Med 27(5):521\u2013533","journal-title":"Semin Respir Crit Care Med"},{"key":"3806_CR5","doi-asserted-by":"crossref","unstructured":"Stewart S, Fishbein MC, Snell GI et\u00a0al (2007) Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J\u00a0Heart Lung Transplant 26(12):1229\u20131242","DOI":"10.1016\/j.healun.2007.10.017"},{"key":"3806_CR6","doi-asserted-by":"crossref","unstructured":"Estenne M, Maurer JR, Boehler A et\u00a0al (2002) Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J\u00a0Heart Lung Transplant 21(3):297\u2013310","DOI":"10.1016\/S1053-2498(02)00398-4"},{"key":"3806_CR7","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1164\/rccm.200609-1344OC","volume":"175","author":"Lama","year":"2007","unstructured":"Lama VN, Murray S, Lonigro RJ et\u00a0al (2007) Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients. Am J Respir Crit Care Med 175(11):1192\u20131198","journal-title":"Am J Respir Crit Care Med"},{"key":"3806_CR8","doi-asserted-by":"crossref","unstructured":"Vermuelen KM, Bij W van der, Erasmus ME, TenVergert EM (2007) Long-term health-related quality of life after lung transplantation: different predictors for different dimensions. J\u00a0Heart Lung Transplant 26(2):188\u2013193","DOI":"10.1016\/j.healun.2006.11.006"},{"key":"3806_CR9","doi-asserted-by":"crossref","first-page":"e90828","DOI":"10.1371\/journal.pone.0090828","volume":"9","author":"Suhling","year":"2014","unstructured":"Suhling H, Rademacher J, Zinowsky I et\u00a0al (2014) Conventional vs. tablet computer-based patient education following lung transplantation \u2013 a randomized controlled trial. PLoS One 9(6):e90828","journal-title":"PLoS One"},{"key":"3806_CR10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000295981.84633.bc","volume":"85","author":"Gottlieb","year":"2008","unstructured":"Gottlieb J, Szangolies J, Koehnlein T et\u00a0al (2008) Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation 85(1):36\u201341","journal-title":"Transplantation"},{"key":"3806_CR11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/ajt.12155","volume":"13","author":"Greer","year":"2013","unstructured":"Greer M, Dierich M, De Wall C et\u00a0al (2013) Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients. Am J Transplant 13(4):911\u2013918","journal-title":"Am J Transplant"},{"key":"3806_CR12","doi-asserted-by":"crossref","unstructured":"Avery RK (2003) Cardiac-allograft vasculopathy. N\u00a0Engl J Med 349:829\u2013830","DOI":"10.1056\/NEJMp038124"},{"key":"3806_CR13","unstructured":"Billingham ME (1992) Histopathology of graft coronary disease. J\u00a0Heart Lung Transplant 11:38\u201344"},{"key":"3806_CR14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1600-6143.2004.00434.x","volume":"4","author":"Caforio","year":"2004","unstructured":"Caforio ALP, Tona F, Fortina AB et\u00a0al (2004) Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplant 4:962\u2013970","journal-title":"Am J Transplant"},{"key":"3806_CR15","doi-asserted-by":"crossref","unstructured":"Eisen HJ, Tuzcu EM, Dorent R et\u00a0al (2003) Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N\u00a0Engl J Med 349:847\u2013858","DOI":"10.1056\/NEJMoa022171"},{"key":"3806_CR16","doi-asserted-by":"crossref","unstructured":"Haverich A, Kallenbach K (2001) Modifizierte Endothelzellen bei Graftvaskulopathie. Z\u00a0Kardiol 90:939\u2013945","DOI":"10.1007\/s003920170064"},{"key":"3806_CR17","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/CIRCULATIONAHA.106.647149","volume":"116","author":"Hiemann","year":"2007","unstructured":"Hiemann NE, Wellnhofer E, Knosalla C et\u00a0al (2007) Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713\u00a0endomyocardial biopsies. Circulation 116:1274\u20131282","journal-title":"Circulation"},{"key":"3806_CR18","doi-asserted-by":"crossref","unstructured":"Kobashigawa JA, Moriguchi JD, Laks H et\u00a0al (2005) Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients. J\u00a0Heart Lung Transplant 24:1736\u20131740","DOI":"10.1016\/j.healun.2005.02.009"},{"key":"3806_CR19","doi-asserted-by":"crossref","unstructured":"Lund LH, Edwards LB, Kucheryavaya AY et\u00a0al for the International Society of Heart and Lung Transplantation (2014) The Registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report \u2013 2014; focus theme: retransplantation. J\u00a0Heart Lung Transplant 33:996\u20131008","DOI":"10.1016\/j.healun.2014.08.003"},{"key":"3806_CR20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","volume":"108","author":"Mancini","year":"2003","unstructured":"Mancini D, Pinney S, Burkhoff D et\u00a0al (2003) Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 108:48\u201353","journal-title":"Circulation"},{"key":"3806_CR21","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/ki.2010.417","volume":"78","author":"Millington","year":"2010","unstructured":"Millington TM, Madsen JC (2010) Innate immunity and cardiac allograft rejection. Kidney Int 78:S18\u2013S21","journal-title":"Kidney Int"},{"key":"3806_CR22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00001573-200403000-00019","volume":"19","author":"Pinney","year":"2004","unstructured":"Pinney SP, Mancini D (2004) Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment. Curr Opin Cardiol 19:170\u2013176","journal-title":"Curr Opin Cardiol"},{"key":"3806_CR23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/TP.0000000000000405","volume":"98","author":"Zhang","year":"2014","unstructured":"Zhang ZX, Huang X, Jiang J et\u00a0al (2014) Natural killer cells play a critical role in cardiac allograft vasculopathy in an interleukin-6-dependent manner. Transplantation 98:1029\u20131039","journal-title":"Transplantation"},{"key":"3806_CR24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000658-200010000-00004","volume":"232","author":"Jain","year":"2000","unstructured":"Jain A, Reyes J, Kashyap R et\u00a0al (2000) Long-term survival after liver transplantation in 4,000\u00a0consecutive patients at a single center. Ann Surg 232(4):490\u2013500","journal-title":"Ann Surg"},{"key":"3806_CR25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/ctr.12364","volume":"28","author":"Wong","year":"2014","unstructured":"Wong RJ, Chou C, Bonham CA et\u00a0al (2014) Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002\u20132012 United Network for Organ Sharing data. Clin Transplant 28(6):713\u2013721","journal-title":"Clin Transplant"},{"key":"3806_CR26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.21280","volume":"44","author":"Banff","year":"2006","unstructured":"Banff Working Group, Demetris AJ, Adeyi O et\u00a0al (2006) Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 44(2):489\u2013501","journal-title":"Hepatology"},{"key":"3806_CR27","doi-asserted-by":"crossref","unstructured":"Neumann UP, Langrehr JM, Neuhaus P (2002) Chronic rejection after human liver transplantation. Graft 102(5)","DOI":"10.1177\/1522162802005002009"},{"key":"3806_CR28","doi-asserted-by":"crossref","unstructured":"Hubscher SG (2011) What is the long-term outcome of the liver allograft? J\u00a0Hepatol 55(3):702\u2013717","DOI":"10.1016\/j.jhep.2011.03.005"},{"key":"3806_CR29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MOT.0b013e3283614a10","volume":"18","author":"O","year":"2013","unstructured":"O\u2019Leary JG, Klintmalm GB (2013) Impact of donor-specific antibodies on results of liver transplantation. Curr Opin Organ Transplant 18(3):279\u2013284","journal-title":"Curr Opin Organ Transplant"},{"key":"3806_CR30","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/lt.23948","volume":"20","author":"O","year":"2014","unstructured":"O\u2019Leary JG, Michelle Shiller S, Bellamy C et\u00a0al (2014) Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features. Liver Transpl 20(10):1244\u20131255","journal-title":"Liver Transpl"},{"key":"3806_CR31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ajt.13153","volume":"15","author":"O","year":"2015","unstructured":"O\u2019Leary JG, Kaneku H, Banuelos N et\u00a0al (2015) Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant 15(4):1003\u20131013","journal-title":"Am J Transplant"},{"key":"3806_CR32","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","volume":"13","author":"Kaneku","year":"2013","unstructured":"Kaneku H, O\u2019Leary JG, Banuelos N et\u00a0al (2013) De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients. Am J Transplant 13(6):1541\u20131548","journal-title":"Am J Transplant"},{"key":"3806_CR33","unstructured":"Nickeleit V Mengel M, Colvin R (2015) Renal transplant pathology. Jennette JC., Olson JL, Silva FG, D\u2019Agati VD (Hrsg) Heptinstall\u2019s Pathology of the Kidney, 7.\u00a0Aufl. Wolters Kluwer, Philadelphia\/PA"},{"key":"3806_CR34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/TP.0b013e31825f4df4","volume":"94","author":"Liapis","year":"2012","unstructured":"Liapis G, Singh HK, Derebail VK et\u00a0al (2012) Diagnostic significance of peritubular capillary basement membrane multilaminations in kidney allografts: old concepts revisited. Transplantation 94:620\u2013629","journal-title":"Transplantation"},{"key":"3806_CR35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MOT.0000000000000189","volume":"20","author":"Randhawa","year":"2015","unstructured":"Randhawa P (2015) T-cell-mediated rejection of the kidney in the era of donor-specific antibodies: diagnostic challenges and clinical significance. Curr Opin Organ Transplant 20:325\u2013332","journal-title":"Curr Opin Organ Transplant"},{"key":"3806_CR36","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0041-1345(98)02003-X","volume":"31","author":"Mihatsch","year":"1999","unstructured":"Mihatsch MJ, Nickeleit V, Gudat F (1999) Morphologic criteria of chronic renal allograft rejection. Transplant Proc 31:1295\u20131297","journal-title":"Transplant Proc"},{"key":"3806_CR37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","volume":"14","author":"Haas","year":"2014","unstructured":"Haas M, Sis B, Racusen LC et\u00a0al (2014) Banff 2013 Meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14:272\u2013283","journal-title":"Am J Transplant"},{"key":"3806_CR38","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/j.1600-6143.2010.03240.x","volume":"10","author":"Mannon","year":"2010","unstructured":"Mannon RB, Matas AJ, Grande J et\u00a0al (2010) Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant 10:2066\u20132073","journal-title":"Am J Transplant"},{"key":"3806_CR39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nri1702","volume":"5","author":"Colvin","year":"2005","unstructured":"Colvin RB, Smith RN (2005) Antibody-mediated organ-allograft rejection. Nat Rev Immunol 5:807\u2013817","journal-title":"Nat Rev Immunol"},{"key":"3806_CR40","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","volume":"9","author":"Einecke","year":"2009","unstructured":"Einecke G, Sis B, Reeve J et\u00a0al (2009) Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 9:2520\u20132531","journal-title":"Am J Transplant"},{"key":"3806_CR41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","volume":"90","author":"Gaston","year":"2010","unstructured":"Gaston RS, Cecka JM, Kasiske BL et\u00a0al (2010) Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 90:68\u201374","journal-title":"Transplantation"},{"key":"3806_CR42","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/ndt\/16.10.2058","volume":"16","author":"Regele","year":"2001","unstructured":"Regele H, Exner M, Watschinger B et\u00a0al (2001) Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 16:2058\u20132066","journal-title":"Nephrol Dial Transplant"},{"key":"3806_CR43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3181\/0707-MR-190","volume":"Med","author":"Kisseleva","year":"2008","unstructured":"Kisseleva T, Brenner DA (2008) Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 233:109\u2013122","journal-title":"Exp Biol"},{"key":"3806_CR44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1523-1755.2004.00773.x","volume":"66","author":"Kluth","year":"2004","unstructured":"Kluth DC, Erwig LP, Rees AJ (2004) Multiple facets of macrophages in renal injury. Kidney Int 66:542\u2013557","journal-title":"Kidney Int"},{"key":"3806_CR45","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/ki.2013.300","volume":"85","author":"Halloran","year":"2014","unstructured":"Halloran PF, Reeve JP, Pereira AB et\u00a0al (2014) Antibody-mediated rejection, T\u00a0cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies. Kidney Int 85:258\u2013264","journal-title":"Kidney Int"},{"key":"3806_CR46","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1600-6143.2010.03053.x","volume":"10","author":"Halloran","year":"2010","unstructured":"Halloran PF (2010) T\u00a0cell-mediated rejection of kidney transplants: a personal viewpoint. Am J Transplant 10:1126\u20131134","journal-title":"Am J Transplant"},{"key":"3806_CR47","doi-asserted-by":"crossref","unstructured":"Park WD, Griffin MD, Cornell LD et\u00a0al (2010) Fibrosis with inflammation at one year predicts transplant functional decline. J\u00a0Am Soc Nephrol 21:1987\u20131997","DOI":"10.1681\/ASN.2010010049"},{"key":"3806_CR48","doi-asserted-by":"crossref","unstructured":"Shishido S, Asanuma H, Nakai H et\u00a0al (2003) The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J\u00a0Am Soc Nephrol 14:1046\u20131052","DOI":"10.1097\/01.ASN.0000056189.02819.32"},{"key":"3806_CR49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","volume":"12","author":"Sellares","year":"2012","unstructured":"Sellares J, Freitas DG de, Mengel M et\u00a0al (2012) Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 12:388\u2013399","journal-title":"Am J Transplant"},{"key":"3806_CR50","doi-asserted-by":"crossref","unstructured":"Lefaucheur C, Viglietti D, Bentlejewski C et\u00a0al (2015) IgG donor-specific anti-human hla antibody subclasses and kidney allograft antibody-mediated injury. J\u00a0Am Soc Nephrol (im Druck)","DOI":"10.1681\/ASN.2014111120"},{"key":"3806_CR51","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MOT.0b013e3283636e55","volume":"18","author":"Dragun","year":"2013","unstructured":"Dragun D, Catar R, Philippe A (2013) Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance. Curr Opin Organ Transplant 18:430\u2013435","journal-title":"Curr Opin Organ Transplant"},{"key":"3806_CR52","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/ndt\/gfg139","volume":"18","author":"Ivanyi","year":"2003","unstructured":"Ivanyi B (2003) Transplant capillaropathy and transplant glomerulopathy: ultrastructural markers of chronic renal allograft rejection. Nephrol Dial Transplant 18:655\u2013660","journal-title":"Nephrol Dial Transplant"},{"key":"3806_CR53","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1600-6143.2011.03926.x","volume":"12","author":"Mengel","year":"2012","unstructured":"Mengel M, Sis B, Haas M et\u00a0al (2012) Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant 12:563\u2013570","journal-title":"Am J Transplant"},{"key":"3806_CR54","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/j.1600-6143.2009.02761.x","volume":"9","author":"Sis","year":"2009","unstructured":"Sis B, Jhangri GS, Bunnag S et\u00a0al (2009) Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 9:2312\u20132323","journal-title":"Am J Transplant"},{"key":"3806_CR55","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/14656566.2011.525219","volume":"12","author":"Lucas","year":"2011","unstructured":"Lucas JG, Co JP, Nwaogwugwu UT et\u00a0al (2011) Antibody-mediated rejection in kidney transplantation: an update. Expert Opin Pharmacother 12:579\u2013592","journal-title":"Expert Opin Pharmacother"},{"key":"3806_CR56","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1432-2277.2012.01453.x","volume":"25","author":"Fehr","year":"2012","unstructured":"Fehr T, Gaspert A (2012) Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale. Transpl Int 25:623\u2013632","journal-title":"Transpl Int"},{"key":"3806_CR57","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/j.transproceed.2008.03.123","volume":"40","author":"Pefaur","year":"2008","unstructured":"Pefaur J, Diaz P, Panace R et\u00a0al (2008) Early and late humoral rejection: a clinicopathologic entity in two times. Transplant Proc 40:3229\u20133236","journal-title":"Transplant Proc"},{"key":"3806_CR58","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.ki.5001552","volume":"70","author":"Sun","year":"2006","unstructured":"Sun Q, Liu ZH, Ji S et\u00a0al (2006) Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation. Kidney Int 70:377\u2013383","journal-title":"Kidney Int"},{"key":"3806_CR59","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/TP.0b013e318218e901","volume":"91","author":"Walsh","year":"2011","unstructured":"Walsh RC, Brailey P, Girnita A et\u00a0al (2011) Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition. Transplantation 91:1218\u20131226","journal-title":"Transplantation"},{"key":"3806_CR60","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","volume":"86","author":"Everly","year":"2008","unstructured":"Everly MJ, Everly JJ, Susskind B et\u00a0al (2008) Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation 86:1754\u20131761","journal-title":"Transplantation"},{"key":"3806_CR61","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/ndt\/gfr465","volume":"27","author":"Waiser","year":"2012","unstructured":"Waiser J, Budde K, Schutz M et\u00a0al (2012) Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection. Nephrol Dial Transplant 27:1246\u20131251","journal-title":"Nephrol Dial Transplant"},{"key":"3806_CR62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1745-6215-15-107","volume":"15","author":"Eskandary","year":"2014","unstructured":"Eskandary F, Bond G, Schwaiger E et\u00a0al (2014) Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial. Trials 15:107","journal-title":"Trials"},{"key":"3806_CR63","unstructured":"ClinicalTrials.gov. http:\/\/clinicaltrials.gov\/show\/NCT01630538. Zugegriffen: 6.\u00a0Dezember 2015"},{"key":"3806_CR64","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1432-2277.2008.00653.x","volume":"21","author":"Ishida","year":"2008","unstructured":"Ishida H, Omoto K, Shimizu T et\u00a0al (2008) Usefulness of splenectomy for chronic active antibody-mediated rejection after renal transplantation. Transpl Int 21:602\u2013604","journal-title":"Transpl Int"},{"key":"3806_CR65","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","volume":"11","author":"Stegall","year":"2011","unstructured":"Stegall MD, Diwan T, Raghavaiah S et\u00a0al (2011) Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant 11:2405\u20132413","journal-title":"Am J Transplant"},{"key":"3806_CR66","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","volume":"15","author":"Cornell","year":"2015","unstructured":"Cornell LD, Schinstock CA, Gandhi MJ et\u00a0al (2015) Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1\u00a0year. Am J Transplant 15:1293\u20131302","journal-title":"Am J Transplant"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-015-3806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-015-3806-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-015-3806-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T20:01:16Z","timestamp":1567540876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-015-3806-9"}},"subtitle":["Unterschiede und \u00c4hnlichkeiten bei verschiedenen soliden Organtransplantationen","Differences and similarities in various solid organ transplants"],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["3806"],"URL":"https:\/\/doi.org\/10.1007\/s00108-015-3806-9","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}